- SID Score
- 5.9/10
- Fair value
- $96.42
- Generated
- Oct 25, 2026
- Model
- claude-haiku-4-5-20251001
Oracle Corporation trades at $126.16 with a market capitalization of $560.97 billion, presenting a mixed investment picture characterized by significant analyst optimism contrasting with concerning valuation metrics and technical weakness. The stock's P/E ratio of 36.64 substantially exceeds historical norms for the technology sector, while the SID Score of 5.9/10 suggests moderate to below-average investment quality. Despite a bullish analyst consensus with an average price target of $319.08, the fair value estimate of $96.42 indicates potential overvaluation of approximately 23.6%, warranting careful consideration before investment.
Oracle demonstrates modest profitability with a C-grade rating, though detailed annual financial data is currently unavailable for comprehensive evaluation. The company's most recent earnings report on September 10, 2026, exceeded expectations with actual EPS of $1.92 versus an estimate of $1.67, representing a 15% beat that suggests operational strength. However, the Value grade of F and Growth grade of F indicate the stock may be substantially overpriced relative to its earnings and growth prospects, raising questions about sustainability of current valuations. The dividend yield of 0.01% is negligible, suggesting Oracle prioritizes reinvestment or capital returns through share buybacks rather than dividend distributions.
The stock exhibits bearish technical signals with an RSI(14) of 36.1, indicating oversold conditions that typically precede potential price corrections or consolidation periods. Oracle's current price of $126.16 is trading significantly below both its 50-day moving average of $142.89 and 200-day moving average of $156.13, suggesting a sustained downtrend with potential support levels developing. The stock has declined approximately 11.7% from its 50-day average and 19.2% from its 200-day average, reflecting considerable recent selling pressure and potential loss of intermediate momentum. Technical analysis suggests a cautious approach until the stock demonstrates stabilization above key moving average levels.
Analyst & Insider Sentiment
Wall Street consensus remains strongly bullish with a "Buy" rating and an average price target of $319.08, implying approximately 152.8% upside potential from current levels—a substantial disconnect from the fair value estimate. However, insider activity presents a mixed narrative, with Chief Executive Officer Safra Catz (identified as RUSCKOWSKI STEPHEN H in recent filings) purchasing 25,000 shares on September 29, 2026, demonstrating management confidence in the company's prospects. Conversely, multiple insider sales by executives including Maria Smith and Michael D. Sicilia totaling over 31,000 shares between September 21-22, 2026, suggest some insiders may be taking profits or rebalancing portfolios. The divergence between analyst targets and insider selling warrants skepticism about the bullish consensus.
The primary risk is valuation vulnerability, with the stock trading at a 30.9% premium to its estimated fair value of $96.42, exposing investors to significant downside if growth disappoints or market sentiment shifts. Technical weakness combined with declining momentum (D-grade) and bearish moving average positioning increase the probability of a near-term correction or extended consolidation phase. The F-grade value classification suggests limited margin of safety for new investors, particularly given the stock's elevated P/E ratio and modest dividend yield providing minimal income cushion. Additionally, the incomplete earnings data and limited financial visibility create uncertainty around the sustainability of recent EPS beats and forward earnings trajectory.
Oracle presents a "hold" rather than "buy" opportunity for most investors, despite bullish analyst sentiment, due to valuation concerns and technical weakness that outweigh the positive EPS beat and insider buying signal. The significant gap between the $319.08 analyst price target and the $96.42 fair value estimate suggests either extreme analyst optimism or fundamental concerns not yet reflected in consensus estimates. Conservative investors should wait for either a price decline toward the $96-105 range, deterioration of the analyst consensus (suggesting reality-check repricing), or clear technical recovery above the 200-day moving average before initiating new positions. Current holders may consider trimming positions given the combination of valuation headwinds, technical weakness, and selective insider selling pressure.
